Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CDT

CDT Equity Inc

Sep 12 • 04:00PM ET

0.6000

0.0000 0.00 %

Healthcare • Biotechnology • USA • NASD

Peers: JNJ ABBV MRK AMGN NVS PFE LLY GILD AZN BMY

| Held by: VXF ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-161.06	Insider Own	13.49%	Shs Outstand	2.39M	Perf Week	-49.15%
Market Cap	1.84M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.39M	Perf Month	-67.03%
Enterprise Value	0.58M	PEG	-	EPS next Q	-	Inst Own	0.67%	Short Float	7.74%	Perf Quarter	-75.71%
Income	-19.65M	P/S	-	EPS this Y	-	Inst Trans	-12.40%	Short Ratio	0.12	Perf Half Y	-96.04%
Sales	0.00M	P/B	0.41	EPS next Y	-	ROA	-347.94%	Short Interest	0.11M	Perf YTD	-99.42%
Book/sh	1.47	P/C	0.55	EPS next 5Y	-	ROE	-89.65%	52W High	274.80 -99.78%	Perf Year	-99.69%
Cash/sh	1.09	P/FCF	-	EPS past 3/5Y	-836.46% -	ROIC	-549.59%	52W Low	0.57 4.71%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.76% 8.90%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-60.74%	Oper. Margin	-	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.45	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	14.19	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.45	EPS Q/Q	95.00%	SMA20	-52.04%	Beta	1.85	Target Price	-
Payout	-	Debt/Eq	0.59	Sales Q/Q	-	SMA50	-65.53%	Rel Volume	1.19	Prev Close	0.60
Employees	6	LT Debt/Eq	0.01	Earnings	-	SMA200	-98.13%	Avg Volume	905.72K	Price	0.60
IPO	Mar 28, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,077,530	Change	0.00%

Sep-03-25 08:30AM	CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy (GlobeNewswire) -9.77%
Aug-26-25 08:30AM	CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy (GlobeNewswire) -10.42%
Aug-05-25 08:30AM	Conduit to Change Name to CDT Equity Inc. (GlobeNewswire)
Jul-08-25 08:30AM	Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy (GlobeNewswire)
Jul-07-25 08:30AM	Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries (GlobeNewswire) -17.12%
08:30AM	Loading…
Jun-04-25 08:30AM	Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health (GlobeNewswire) -17.03%
May-22-25 08:30AM	Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market (GlobeNewswire) -12.92%
May-21-25 08:30AM	Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance (GlobeNewswire) -17.91%
May-16-25 08:30AM	Conduit Pharmaceuticals Inc. Announces Reverse Stock Split (GlobeNewswire)
May-09-25 08:30AM	Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases (GlobeNewswire)
May-08-25 08:30AM	Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset (GlobeNewswire) -5.21%
Apr-16-25 08:30AM	Conduit Pharmaceuticals Announces Leadership Changes (GlobeNewswire) -12.97%
Apr-11-25 08:30AM	Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA (tapinarof) with Enhanced Therapeutic and Market Extension Prospects (GlobeNewswire) -14.94%
Apr-10-25 08:30AM	Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program (GlobeNewswire) +72.58%
Apr-07-25 08:30AM	Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization (GlobeNewswire)
08:30AM	Loading…
Mar-31-25 08:30AM	Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases (GlobeNewswire) -12.25%
Mar-19-25 08:30AM	Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 (GlobeNewswire) -8.66%
Mar-07-25 04:53AM	Is Conduit Pharmaceuticals Inc. (CDT) the Best Micro Cap Stock to Buy Now? (Insider Monkey)
Mar-06-25 09:35AM	Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel (GlobeNewswire)
Feb-20-25 08:00AM	Conduit Progresses Phase II of its AI Initiative with Sarborg (GlobeNewswire)
Feb-13-25 08:00AM	Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model (GlobeNewswire) -8.43%
Feb-11-25 09:00AM	Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note (GlobeNewswire)
Feb-08-25 06:08AM	Conduit Pharmaceuticals Inc. (CDT) Advances AI-Driven Drug Development to Phase II (Insider Monkey)
Feb-07-25 08:00AM	Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development (GlobeNewswire) +83.87%
Jan-28-25 05:30AM	Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence (GlobeNewswire) -6.97%
Jan-23-25 08:00AM	Conduit Pharmaceuticals Inc. Announces Reverse Stock Split (GlobeNewswire) -20.00%
Jan-22-25 08:00AM	Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline (GlobeNewswire) -7.41%
Dec-12-24 07:30AM	Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics (GlobeNewswire) -7.13%
Nov-21-24 07:30AM	Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders (GlobeNewswire) +16.90%
Nov-19-24 04:30PM	Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors (GlobeNewswire)
07:40AM	Loading…
Nov-05-24 07:40AM	Conduit Pharmaceuticals announces new addition to autoimmune pipeline (TipRanks) +6.80%
Nov-04-24 07:30AM	Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline (GlobeNewswire) +11.80%
Nov-01-24 04:45PM	Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes (GlobeNewswire)
Aug-28-24 08:00AM	Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -5.54%
Aug-12-24 07:00AM	Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders (GlobeNewswire) -10.53%
Aug-08-24 06:30AM	Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments (GlobeNewswire)
Jul-16-24 02:52PM	Conduit Pharmaceuticals Granted Patent Approval For Autoimmune Diseases Treatment (Exec Edge)
08:12AM	Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today? (InvestorPlace)
07:43AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:30AM	Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases (GlobeNewswire)
Jun-13-24 08:00AM	Conduit Pharmaceuticals to Join Russell 3000 Index (GlobeNewswire) -6.05%
May-29-24 04:21PM	A Presidio Property Trust Major Investment To Be Part of Russell 2000 (GlobeNewswire)
May-15-24 09:53AM	CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q1 2024 (InvestorPlace)
Mar-19-24 10:57AM	Conduit Pharmaceuticals Adds Key Leadership Positions (Exec Edge)
07:00AM	Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer (GlobeNewswire)
Mar-11-24 02:26PM	Conduit Pharmaceuticals Opens New Laboratory in UK (Exec Edge) +32.37%
07:00AM	Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub (GlobeNewswire)
Jan-31-24 08:30AM	Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire) -7.42%
Nov-02-23 08:30AM	Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference (GlobeNewswire)
Oct-30-23 08:39AM	Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today? (InvestorPlace) +49.52%
Oct-11-23 08:30AM	Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656 (GlobeNewswire) -12.00%
Oct-06-23 09:29AM	Conduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipeline (Exec Edge) -13.83%
08:30AM	Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW) (GlobeNewswire)
Sep-22-23 09:01AM	Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination (GlobeNewswire)
Sep-20-23 05:40PM	Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited (ACCESSWIRE) -8.94% +32.32%
Sep-13-23 08:30AM	Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives (GlobeNewswire)
Sep-07-23 04:30PM	Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit (ACCESSWIRE)
Aug-31-23 04:05PM	Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit (ACCESSWIRE)
Aug-16-23 08:30AM	SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited (ACCESSWIRE)

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nirland Ltd	10% Owner	Oct 03 '24	Sale	0.10	1,500,000	156,450	8,400,000	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 04 '24	Sale	0.10	1,368,991	140,458	7,031,009	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 07 '24	Sale	0.10	939,009	96,530	6,092,000	Oct 07 07:38 PM
Nirland Ltd	10% Owner	Oct 01 '24	Sale	0.11	1,250,000	141,375	10,233,177	Oct 02 05:02 PM
Nirland Ltd	10% Owner	Sep 30 '24	Sale	0.12	1,016,823	122,019	11,483,177	Oct 02 05:02 PM
Nirland Ltd	10% Owner	Oct 02 '24	Sale	0.10	333,177	34,251	9,900,000	Oct 02 05:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDT

CDT Equity Inc

Upgrade your FINVIZ experience